Development and validation of a liquid chromatography coupled to a diode array detector (LC-DAD) method for measuring mitotane (DDD) in plasma samples
Author:
Marques Anna Sylvia FerrariORCID,
Alves Atecla Nunciata Lopes,
Mendonca Berenice Bilharinho,
Lima-Valassi Helena PanteliouORCID
Reference16 articles.
1. On precision dosing of oral small molecule drugs in oncology;Lyashchenko;Br J Clin Pharmacol,2021
2. Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study;Hermsen;J Clin Endocrinol Metab,2011
3. CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells;Germano;PLoS One,2018
4. Molecular mechanisms of mitotane action in adrenocortical cancer based on in vitro studies;Lo Iacono;Cancers (Basel),2021
5. Determination of mitotane (DDD) and principal metabolite by a simple HPLC-UV method and its validation in human plasma samples;Luci;Separations,2021